bifidobacterium lactis Search Results


93
ATCC bifidobacterium animalis ssp lactis bi 07
Bifidobacterium Animalis Ssp Lactis Bi 07, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/Bifidobacterium+lactis%2C+Bi-07/pmc04676059-79-27-32
Average 93 stars, based on 1 article reviews
bifidobacterium animalis ssp lactis bi 07 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

95
ATCC b animalis subsp lactis
B Animalis Subsp Lactis, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/Bifidobacterium+animalis+subsp%2E+lactis/pmc08018518-721-44-54
Average 95 stars, based on 1 article reviews
b animalis subsp lactis - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
ATCC bifidobacterium animalis subsp lactis bb 12
Figure 2 Representative 2D gels of the Bif. animalis subsp. lactis BB-12 and Lact. rhamnosus GG strains. Proteins spots identified in the mass spectrometry analysis are labelled. BB-12, Bifidobacterium animalis subsp. lactis BB-12; LGG, Lactobacillus rhamnosus GG; MM, molecular mass; pI, isoelectric point.
Bifidobacterium Animalis Subsp Lactis Bb 12, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/Bifidobacterium+animalis%3B+subsp%2E+lactis/pm24724909-20-33-42
Average 95 stars, based on 1 article reviews
bifidobacterium animalis subsp lactis bb 12 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
DSMZ bifidobacterium animalis subsp lactis strain bb
Figure 2 Representative 2D gels of the Bif. animalis subsp. lactis BB-12 and Lact. rhamnosus GG strains. Proteins spots identified in the mass spectrometry analysis are labelled. BB-12, Bifidobacterium animalis subsp. lactis BB-12; LGG, Lactobacillus rhamnosus GG; MM, molecular mass; pI, isoelectric point.
Bifidobacterium Animalis Subsp Lactis Strain Bb, supplied by DSMZ, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/Bifidobacterium+animalis+subsp%2E+lactis/us12317904-171-7-15
Average 94 stars, based on 1 article reviews
bifidobacterium animalis subsp lactis strain bb - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

95
ATCC bifidobacterium lactis atcc 27536
Figure 2 Representative 2D gels of the Bif. animalis subsp. lactis BB-12 and Lact. rhamnosus GG strains. Proteins spots identified in the mass spectrometry analysis are labelled. BB-12, Bifidobacterium animalis subsp. lactis BB-12; LGG, Lactobacillus rhamnosus GG; MM, molecular mass; pI, isoelectric point.
Bifidobacterium Lactis Atcc 27536, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/Bifidobacterium+animalis%3B+subsp%2E+lactis/pmc08779761-228-25-27
Average 95 stars, based on 1 article reviews
bifidobacterium lactis atcc 27536 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

95
ATCC bifidobacterium animalis subsp lactis jcm 10602
Figure 2 Representative 2D gels of the Bif. animalis subsp. lactis BB-12 and Lact. rhamnosus GG strains. Proteins spots identified in the mass spectrometry analysis are labelled. BB-12, Bifidobacterium animalis subsp. lactis BB-12; LGG, Lactobacillus rhamnosus GG; MM, molecular mass; pI, isoelectric point.
Bifidobacterium Animalis Subsp Lactis Jcm 10602, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/Bifidobacterium+animalis+subsp%2E+lactis/us12006527-172-14-46
Average 95 stars, based on 1 article reviews
bifidobacterium animalis subsp lactis jcm 10602 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

92
ATCC probiotic bacteria
Bacterial strains used in the research, along with an indication of their origin.
Probiotic Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/Bifidobacterium+animalis+subsp%2E+lactis/pmc10968585-2-3-6
Average 92 stars, based on 1 article reviews
probiotic bacteria - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

92
ATCC bifidobacterium lactis idcc 4301 bl strain
Bacterial strains used in the research, along with an indication of their origin.
Bifidobacterium Lactis Idcc 4301 Bl Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/Bifidobacterium+animalis+%3Bsubsp%2E+lactis+%3BStrain%3A+IDCC+4301/pm37051343-41-1-7
Average 92 stars, based on 1 article reviews
bifidobacterium lactis idcc 4301 bl strain - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

90
VSL Pharmaceuticals bifidobacterium animalis subsp. lactis bi04
Information extracted from the literature regarding article specifics and corresponding research findings for lactobacilli as probiotic strains.
Bifidobacterium Animalis Subsp. Lactis Bi04, supplied by VSL Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/bifidobacterium+animalis+subsp++lactis+bi04/pmc11085918-5-36-54
Average 90 stars, based on 1 article reviews
bifidobacterium animalis subsp. lactis bi04 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioResource International Inc bifidobacterium strains
Disruption of a conserved bile acid biosynthetic pathway in different <t>Bifidobacterium</t> strains using the same editing plasmid. ( A ) Comparison of editing efficiencies using the cBEST2- bsh -PS1, cBEST3- bsh -PS1, and cBEST4- bsh -PS1 plasmids across Bifidobacterium strains NCIMB 8809, DSM 20219, and DSM 20088. Editing efficiencies for each experiment were expressed as (number of edited colonies / number of sequenced colonies) with data from independent transformations separated by commas. For transformations yielding less than five transformants, all transformants were sequenced. Data shaded orange were first presented in and reproduced here to facilitate comparison between the different constructs. ( B ) Editing window for all tested conditions. ( C ) Successful bsh (W22*) strains using the identical cBEST4- bsh -PS1 plasmid. Sequencing results confirmed the precise introduction of the stop codon due to successful C-to-T edits (red frames). ( D ) Biosynthesis pathway from taurocholic acid (TCA) to deoxycholic acid (DCA) by gut microbiota. Bile salt hydrolase ( bsh ) deconjugates TCA into cholic acid (CA), and bile acid-inducible operon ( bai ) converts CA into DCA. ( E ) Individual wild-type or bsh (W22*) strains cultured in TCA-supplemented MRSC broth for 24 h. ( F ) LC-MS/MS quantification of TCA and CA metabolites in indicated Bifidobacterium wild-type and bsh (W22*) strains. ( G ) Three Bifidobacterium wild-type or bsh (W22*) strains with Clostridium scindens DSM 5676 ( Clos .) co-cultures in TCA-supplemented MRSC broth for 24 h. ( H ) LC-MS/MS quantification of TCA, CA, and DCA metabolites in two co-cultures. n = 4, biological replicates; error bars, SEM. nt, no transformant obtained.
Bifidobacterium Strains, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/bifidobacterium+lactis/pmc12016496-141-0-11
Average 90 stars, based on 1 article reviews
bifidobacterium strains - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
DuPont de Nemours bifidobacterium lactis
Disruption of a conserved bile acid biosynthetic pathway in different <t>Bifidobacterium</t> strains using the same editing plasmid. ( A ) Comparison of editing efficiencies using the cBEST2- bsh -PS1, cBEST3- bsh -PS1, and cBEST4- bsh -PS1 plasmids across Bifidobacterium strains NCIMB 8809, DSM 20219, and DSM 20088. Editing efficiencies for each experiment were expressed as (number of edited colonies / number of sequenced colonies) with data from independent transformations separated by commas. For transformations yielding less than five transformants, all transformants were sequenced. Data shaded orange were first presented in and reproduced here to facilitate comparison between the different constructs. ( B ) Editing window for all tested conditions. ( C ) Successful bsh (W22*) strains using the identical cBEST4- bsh -PS1 plasmid. Sequencing results confirmed the precise introduction of the stop codon due to successful C-to-T edits (red frames). ( D ) Biosynthesis pathway from taurocholic acid (TCA) to deoxycholic acid (DCA) by gut microbiota. Bile salt hydrolase ( bsh ) deconjugates TCA into cholic acid (CA), and bile acid-inducible operon ( bai ) converts CA into DCA. ( E ) Individual wild-type or bsh (W22*) strains cultured in TCA-supplemented MRSC broth for 24 h. ( F ) LC-MS/MS quantification of TCA and CA metabolites in indicated Bifidobacterium wild-type and bsh (W22*) strains. ( G ) Three Bifidobacterium wild-type or bsh (W22*) strains with Clostridium scindens DSM 5676 ( Clos .) co-cultures in TCA-supplemented MRSC broth for 24 h. ( H ) LC-MS/MS quantification of TCA, CA, and DCA metabolites in two co-cultures. n = 4, biological replicates; error bars, SEM. nt, no transformant obtained.
Bifidobacterium Lactis, supplied by DuPont de Nemours, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/bifidobacterium+lactis/us10576112-75-77-84
Average 90 stars, based on 1 article reviews
bifidobacterium lactis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Winclove Bio Industries BV bifidobacterium animalis subsp. lactis w52 ( b. lactis w52)
Disruption of a conserved bile acid biosynthetic pathway in different <t>Bifidobacterium</t> strains using the same editing plasmid. ( A ) Comparison of editing efficiencies using the cBEST2- bsh -PS1, cBEST3- bsh -PS1, and cBEST4- bsh -PS1 plasmids across Bifidobacterium strains NCIMB 8809, DSM 20219, and DSM 20088. Editing efficiencies for each experiment were expressed as (number of edited colonies / number of sequenced colonies) with data from independent transformations separated by commas. For transformations yielding less than five transformants, all transformants were sequenced. Data shaded orange were first presented in and reproduced here to facilitate comparison between the different constructs. ( B ) Editing window for all tested conditions. ( C ) Successful bsh (W22*) strains using the identical cBEST4- bsh -PS1 plasmid. Sequencing results confirmed the precise introduction of the stop codon due to successful C-to-T edits (red frames). ( D ) Biosynthesis pathway from taurocholic acid (TCA) to deoxycholic acid (DCA) by gut microbiota. Bile salt hydrolase ( bsh ) deconjugates TCA into cholic acid (CA), and bile acid-inducible operon ( bai ) converts CA into DCA. ( E ) Individual wild-type or bsh (W22*) strains cultured in TCA-supplemented MRSC broth for 24 h. ( F ) LC-MS/MS quantification of TCA and CA metabolites in indicated Bifidobacterium wild-type and bsh (W22*) strains. ( G ) Three Bifidobacterium wild-type or bsh (W22*) strains with Clostridium scindens DSM 5676 ( Clos .) co-cultures in TCA-supplemented MRSC broth for 24 h. ( H ) LC-MS/MS quantification of TCA, CA, and DCA metabolites in two co-cultures. n = 4, biological replicates; error bars, SEM. nt, no transformant obtained.
Bifidobacterium Animalis Subsp. Lactis W52 ( B. Lactis W52), supplied by Winclove Bio Industries BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bifidobacterium+lactis/bifidobacterium+lactis+w51/pmc06193377-309-38-60
Average 90 stars, based on 1 article reviews
bifidobacterium animalis subsp. lactis w52 ( b. lactis w52) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2 Representative 2D gels of the Bif. animalis subsp. lactis BB-12 and Lact. rhamnosus GG strains. Proteins spots identified in the mass spectrometry analysis are labelled. BB-12, Bifidobacterium animalis subsp. lactis BB-12; LGG, Lactobacillus rhamnosus GG; MM, molecular mass; pI, isoelectric point.

Journal: Journal of applied microbiology

Article Title: Assessment of stress tolerance acquisition in the heat-tolerant derivative strains of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus rhamnosus GG.

doi: 10.1111/jam.12520

Figure Lengend Snippet: Figure 2 Representative 2D gels of the Bif. animalis subsp. lactis BB-12 and Lact. rhamnosus GG strains. Proteins spots identified in the mass spectrometry analysis are labelled. BB-12, Bifidobacterium animalis subsp. lactis BB-12; LGG, Lactobacillus rhamnosus GG; MM, molecular mass; pI, isoelectric point.

Article Snippet: In this study, we used two-dimensional differential ingel electrophoresis (2D-DIGE) coupled with mass spectrometry, together with reverse transcriptase-quantitative PCR (RT-qPCR), to assess the heat response in the two most commonly used probiotic strains, Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus rhamnosus GG (ATCC 53013), and to compare them with their previously obtained heat-tolerant derivatives (BB-12 HS and LGG HS) (du Toit et al. 2013).

Techniques: Mass Spectrometry

Bacterial strains used in the research, along with an indication of their origin.

Journal: Antioxidants

Article Title: Exploring Beneficial Properties of Haskap Berry Leaf Compounds for Gut Health Enhancement

doi: 10.3390/antiox13030357

Figure Lengend Snippet: Bacterial strains used in the research, along with an indication of their origin.

Article Snippet: Bifidobacterium animalis , Probiotic bacteria , ATCC BAA-2848.

Techniques: Bacteria

Information extracted from the literature regarding article specifics and corresponding research findings for lactobacilli as probiotic strains.

Journal: Nutrients

Article Title: The Influence of Probiotic Lactobacilli on COVID-19 and the Microbiota

doi: 10.3390/nu16091350

Figure Lengend Snippet: Information extracted from the literature regarding article specifics and corresponding research findings for lactobacilli as probiotic strains.

Article Snippet: Laterza, L. et al., 2023 [ ] , Italy , 19 , Missing information , 19 post-COVID-19 patients , Lactobacillus paracasei BP07, Lactobacillus helveticus BD08, Lactobacillus plantarum BP06, Lactobacillus acidophilus BA05, Bifidobacterium animalis subsp. lactis BL03, Bifidobacterium breve BB02, Bifidobacterium animalis subsp. lactis BI04, and Streptococcus thermophilus BT01 (VSL#3 ® , lot number 909031, VSL Pharmaceuticals, Gaithersburg, MD, USA) , 8 weeks , Significant reduction in citrulline, TNF-ALFA, IL-6, and IL-12RA.

Techniques: Probiotics, Marker, Cell Counting

Disruption of a conserved bile acid biosynthetic pathway in different Bifidobacterium strains using the same editing plasmid. ( A ) Comparison of editing efficiencies using the cBEST2- bsh -PS1, cBEST3- bsh -PS1, and cBEST4- bsh -PS1 plasmids across Bifidobacterium strains NCIMB 8809, DSM 20219, and DSM 20088. Editing efficiencies for each experiment were expressed as (number of edited colonies / number of sequenced colonies) with data from independent transformations separated by commas. For transformations yielding less than five transformants, all transformants were sequenced. Data shaded orange were first presented in and reproduced here to facilitate comparison between the different constructs. ( B ) Editing window for all tested conditions. ( C ) Successful bsh (W22*) strains using the identical cBEST4- bsh -PS1 plasmid. Sequencing results confirmed the precise introduction of the stop codon due to successful C-to-T edits (red frames). ( D ) Biosynthesis pathway from taurocholic acid (TCA) to deoxycholic acid (DCA) by gut microbiota. Bile salt hydrolase ( bsh ) deconjugates TCA into cholic acid (CA), and bile acid-inducible operon ( bai ) converts CA into DCA. ( E ) Individual wild-type or bsh (W22*) strains cultured in TCA-supplemented MRSC broth for 24 h. ( F ) LC-MS/MS quantification of TCA and CA metabolites in indicated Bifidobacterium wild-type and bsh (W22*) strains. ( G ) Three Bifidobacterium wild-type or bsh (W22*) strains with Clostridium scindens DSM 5676 ( Clos .) co-cultures in TCA-supplemented MRSC broth for 24 h. ( H ) LC-MS/MS quantification of TCA, CA, and DCA metabolites in two co-cultures. n = 4, biological replicates; error bars, SEM. nt, no transformant obtained.

Journal: Applied and Environmental Microbiology

Article Title: Highly efficient CRISPR-Cas9 base editing in Bifidobacterium with bypass of restriction modification systems

doi: 10.1128/aem.01985-24

Figure Lengend Snippet: Disruption of a conserved bile acid biosynthetic pathway in different Bifidobacterium strains using the same editing plasmid. ( A ) Comparison of editing efficiencies using the cBEST2- bsh -PS1, cBEST3- bsh -PS1, and cBEST4- bsh -PS1 plasmids across Bifidobacterium strains NCIMB 8809, DSM 20219, and DSM 20088. Editing efficiencies for each experiment were expressed as (number of edited colonies / number of sequenced colonies) with data from independent transformations separated by commas. For transformations yielding less than five transformants, all transformants were sequenced. Data shaded orange were first presented in and reproduced here to facilitate comparison between the different constructs. ( B ) Editing window for all tested conditions. ( C ) Successful bsh (W22*) strains using the identical cBEST4- bsh -PS1 plasmid. Sequencing results confirmed the precise introduction of the stop codon due to successful C-to-T edits (red frames). ( D ) Biosynthesis pathway from taurocholic acid (TCA) to deoxycholic acid (DCA) by gut microbiota. Bile salt hydrolase ( bsh ) deconjugates TCA into cholic acid (CA), and bile acid-inducible operon ( bai ) converts CA into DCA. ( E ) Individual wild-type or bsh (W22*) strains cultured in TCA-supplemented MRSC broth for 24 h. ( F ) LC-MS/MS quantification of TCA and CA metabolites in indicated Bifidobacterium wild-type and bsh (W22*) strains. ( G ) Three Bifidobacterium wild-type or bsh (W22*) strains with Clostridium scindens DSM 5676 ( Clos .) co-cultures in TCA-supplemented MRSC broth for 24 h. ( H ) LC-MS/MS quantification of TCA, CA, and DCA metabolites in two co-cultures. n = 4, biological replicates; error bars, SEM. nt, no transformant obtained.

Article Snippet: Bifidobacterium strains and Clostridium scindens DSM 5676 were propagated in the Bioresource Collection and Research Center (BCRC) and cultured in NEOGEN Lactobacilli de Man, Rogosa, and Sharpe broth (LOT #US113980G) containing 0.05% wt/vol L-cysteine (MRSC) at 37°C under anaerobic conditions (80% N 2 , 10% CO 2 , 10% H 2 ) using Whitley DG250 anaerobic workstation.

Techniques: Disruption, Plasmid Preparation, Comparison, Construct, Sequencing, Cell Culture, Liquid Chromatography with Mass Spectroscopy